GB202209167D0 - Vaccine boost methods and compositions - Google Patents
Vaccine boost methods and compositionsInfo
- Publication number
- GB202209167D0 GB202209167D0 GBGB2209167.2A GB202209167A GB202209167D0 GB 202209167 D0 GB202209167 D0 GB 202209167D0 GB 202209167 A GB202209167 A GB 202209167A GB 202209167 D0 GB202209167 D0 GB 202209167D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- vaccine boost
- boost methods
- methods
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2209167.2A GB202209167D0 (en) | 2022-06-22 | 2022-06-22 | Vaccine boost methods and compositions |
PCT/GB2022/053122 WO2023105221A1 (en) | 2021-12-07 | 2022-12-07 | Vaccine boost methods and compositions |
US18/062,817 US20230310591A1 (en) | 2021-12-07 | 2022-12-07 | Vaccine Boost Methods and Compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2209167.2A GB202209167D0 (en) | 2022-06-22 | 2022-06-22 | Vaccine boost methods and compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202209167D0 true GB202209167D0 (en) | 2022-08-10 |
Family
ID=82705411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2209167.2A Ceased GB202209167D0 (en) | 2021-12-07 | 2022-06-22 | Vaccine boost methods and compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202209167D0 (en) |
-
2022
- 2022-06-22 GB GBGB2209167.2A patent/GB202209167D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4117725A4 (en) | Coronavirus vaccine compositions and methods | |
EP4110383A4 (en) | Compositions and methods for mucosal vaccination against sars-cov-2 | |
GB202111040D0 (en) | Compositions and methods | |
IL308201A (en) | Multivalent vaccine compositions and uses thereof | |
EP4084784A4 (en) | Compositions and methods | |
GB202004677D0 (en) | Methods and compositions | |
GB202209167D0 (en) | Vaccine boost methods and compositions | |
GB202117680D0 (en) | Vaccine boost methods and compositions | |
GB202110091D0 (en) | Methods and compositions | |
GB202314361D0 (en) | Vaccine compositions and uses thereof | |
GB202316106D0 (en) | Methods and compositions | |
GB202316109D0 (en) | Methods and compositions | |
GB202311858D0 (en) | Methods and compositions | |
GB202308901D0 (en) | Methods and compositions | |
GB202307563D0 (en) | Methods and compositions | |
GB202305427D0 (en) | Methods and compositions | |
GB202304240D0 (en) | Compositions and methods | |
GB202219851D0 (en) | Compositions and methods | |
GB202209588D0 (en) | Methods and compositions | |
GB202209115D0 (en) | Compositions and methods | |
GB202206268D0 (en) | Compositions and methods | |
GB202205579D0 (en) | Methods and compositions | |
GB202316199D0 (en) | Compositions and methods and uses thereto | |
GB202300911D0 (en) | Therapeutic compositions and methods | |
GB202219334D0 (en) | therapeutic compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |